PIRS Stock Summary and Trading Ideas (Pieris Pharmaceuticals | NASDAQ:PIRS)

Pieris Pharmaceuticals Inc is a clinical-stage biopharmaceutical company, which engages in the discovery and development of the Anticalin class of biotherapeutics. Anticalin proteins are engineered versions of lipocalins, human proteins that naturally bind, store, and transport a wide spectrum of molecules. The Company's clinical pipeline consists of immuno-oncology, or IO, bispecifics in partnership with collaborators, including S095012 (also referred to as PRS-344) targeting PD-L1 and 4-1BB, SGN-BB228 (also referred to as PRS-346) targeting CD228 and 4-1BB, and BOS-342 (also referred to as PRS-342) targeting GPC3 and 4-1BB. Geographically, all the operations of the firm function through the region of the United States.

Pieris Pharmaceuticals trades on the NASDAQ stock market under the symbol PIRS.

As of April 25, 2024, PIRS stock price declined to $11.60 with 26,792 million shares trading.

PIRS has a beta of 2.36, meaning it tends to be more sensitive to market movements. PIRS has a correlation of 0.04 to the broad based SPY ETF.

PIRS has a market cap of $14.35 million. This is considered a Sub-Micro Cap stock.

Last quarter Pieris Pharmaceuticals reported $20 million in Revenue and -$.11 earnings per share. This beat revenue expectation by $12 million and met earnings estimates .

In the last 3 years, PIRS stock traded as high as $492.00 and as low as $10.89.

The top ETF exchange traded funds that PIRS belongs to (by Net Assets): VXF.

PIRS has underperformed the market in the last year with a price return of -83.3% while the SPY ETF gained +23.6%. PIRS has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -9.3% and -18.2%, respectively, while the SPY returned +4.1% and -2.1%, respectively.

PIRS support price is $11.21 and resistance is $12.65 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that PIRS stock will trade within this expected range on the day.